Vaxxinity Reports Second Quarter 2023 Financial Results and Provides Corporate Update

CAPE CANAVERAL, Fla., Aug. 09, 2023 -- Vaxxinity, Inc. ; class='js-l-obf link link--blue'

Related Keywords

Washington ,United States ,United Kingdom ,Boston ,Massachusetts ,Australia ,American ,Alexander Rumyantsev ,Sarah Despres ,Peter Powchik ,Mark Joinnides ,Jon Yu ,Emei ,Michaelj Fox Foundation ,Exchange Commission On ,Nasdaq ,Vaxxinity Inc ,World Vaccine Congress ,American Academy Of Neurology Annual Meeting ,Global Scientific ,Senior Vice President ,Emerging Science Presentation ,American Academy ,Neurology Annual Meeting ,Lessons Learned ,Way Forward ,Fireside Chat ,Therapeutic Area Head ,Infectious Diseases ,Private Securities Litigation Reform Act ,Annual Report ,Exchange Commission ,Markets ,